Catalyst Wire Dossier Catalyst Wire Dossier

Sprimeo

aliskiren · Novartis Europharm Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sprimeo, covering 2012-07-23 to 2012-07-23. Get the full timeline:

Most recent: EMA Withdrawn: Sprimeo (aliskiren) — Novartis Europharm Ltd.

See pricing